[ad_1]
Phibro Animal Health said on February 6, 2023 that its board of directors declared a regular
quarterly dividend of $0.12 per share ($0.48 annualized).
Shareholders of record as of February 28, 2023
will receive the payment on March 22, 2023.
Previously, the company paid $0.12 per share.
At the current share price of $15.75 / share,
the stock’s dividend yield is 3.05%.
Looking back five years and taking a sample every week, the average dividend yield has been
2.00%,
the lowest has been 0.75%,
and the highest has been 3.96%.
The standard deviation of yields is 0.70 (n=236).
The current dividend yield is
1.51 standard deviations
above
the historical average.
Additionally, the company’s dividend payout ratio is 0.54.
The payout ratio tells us how much of a company’s income is paid out in dividends. A payout ratio of one (1.0)
means 100% of the company’s income is paid in a dividend.
A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend – not a
healthy situation.
Companies with few growth prospects are expected to pay out most of their income in dividends, which typically
means a payout ratio between 0.5 and 1.0.
Companies with good growth prospects are expected to retain some earnings in order to invest
in those growth prospects, which translates to a payout ratio of zero to 0.5.
The company has not increased its dividend in the last three years.
Analyst Price Forecast Suggests 8.48% Upside
As of February 11, 2023,
the average one-year price target for Phibro Animal Health is $17.08.
The forecasts range from a low of $12.12 to a high of $21.00.
The average price target represents an increase of 8.48% from its latest reported closing price of $15.75.
The projected annual revenue for Phibro Animal Health
is $1,006MM, an increase of 3.49%.
The projected annual EPS
is $1.25, an increase of 39.45%.
What is the Fund Sentiment?
There are 395 funds or institutions reporting positions in Phibro Animal Health.
This is a decrease
of
4
owner(s) or 1.00% in the last quarter.
Average portfolio weight of all funds dedicated to PAHC is 0.08%,
a decrease
of 16.28%.
Total shares owned by institutions decreased
in the last three months by 2.40% to 23,401K shares.
The put/call ratio of PAHC is 0.66, indicating a
bullish
outlook.
What are large shareholders doing?
Pzena Investment Management
holds 1,969K shares
representing 4.86% ownership of the company.
In it’s prior filing, the firm reported owning 1,922K shares, representing
an increase
of 2.41%.
The firm
decreased
its portfolio allocation in PAHC by 8.29% over the last quarter.
IJR – iShares Core S&P Small-Cap ETF
holds 1,534K shares
representing 3.79% ownership of the company.
In it’s prior filing, the firm reported owning 1,424K shares, representing
an increase
of 7.20%.
The firm
decreased
its portfolio allocation in PAHC by 24.02% over the last quarter.
HRVIX – HEARTLAND VALUE PLUS FUND Investor Class
holds 750K shares
representing 1.85% ownership of the company.
In it’s prior filing, the firm reported owning 785K shares, representing
a decrease
of 4.67%.
The firm
decreased
its portfolio allocation in PAHC by 28.01% over the last quarter.
Heartland Advisors
holds 714K shares
representing 1.76% ownership of the company.
In it’s prior filing, the firm reported owning 769K shares, representing
a decrease
of 7.81%.
The firm
decreased
its portfolio allocation in PAHC by 20.67% over the last quarter.
Millennium Management
holds 656K shares
representing 1.62% ownership of the company.
In it’s prior filing, the firm reported owning 32K shares, representing
an increase
of 95.06%.
The firm
increased
its portfolio allocation in PAHC by 1,240.94% over the last quarter.
Phibro Animal Health Background Information
(This description is provided by the company.)
Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
[ad_2]
Image and article originally from www.nasdaq.com. Read the original article here.